Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.

Gallon J, Coto-Llerena M, Ercan C, Bianco G, Paradiso V, Nuciforo S, Taha-Melitz S, Meier MA, Boldanova T, Pérez-Del-Pulgar S, Rodríguez-Tajes S, von Flüe M, Soysal SD, Kollmar O, Llovet JM, Villanueva A, Terracciano LM, Heim MH, Ng CKY, Piscuoglio S

Open source

DOI: 10.1002/1878-0261.13154
Published: 2022 Feb
Container: Molecular oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/1878-0261.13154,
  title = {Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.},
  author = {Gallon J and Coto-Llerena M and Ercan C and Bianco G and Paradiso V and Nuciforo S and Taha-Melitz S and Meier MA and Boldanova T and Pérez-Del-Pulgar S and Rodríguez-Tajes S and von Flüe M and Soysal SD and Kollmar O and Llovet JM and Villanueva A and Terracciano LM and Heim MH and Ng CKY and Piscuoglio S},
  year = {2022},
  journal = {Molecular oncology},
  doi = {10.1002/1878-0261.13154},
  url = {https://doi.org/10.1002/1878-0261.13154}
}

RIS

TY  - JOUR
TI  - Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.
AU  - Gallon J
AU  - Coto-Llerena M
AU  - Ercan C
AU  - Bianco G
AU  - Paradiso V
AU  - Nuciforo S
AU  - Taha-Melitz S
AU  - Meier MA
AU  - Boldanova T
AU  - Pérez-Del-Pulgar S
AU  - Rodríguez-Tajes S
AU  - von Flüe M
AU  - Soysal SD
AU  - Kollmar O
AU  - Llovet JM
AU  - Villanueva A
AU  - Terracciano LM
AU  - Heim MH
AU  - Ng CKY
AU  - Piscuoglio S
PY  - 2022
JO  - Molecular oncology
DO  - 10.1002/1878-0261.13154
UR  - https://doi.org/10.1002/1878-0261.13154
ER  -

APA

J, G., M, C., C, E., G, B., V, P., S, N., S, T., MA, M., T, B., S, P., S, R., M, V. F., SD, S., O, K., JM, L., A, V., LM, T., MH, H., CKY, N., & S, P. (2022). Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.. Molecular oncology. https://doi.org/10.1002/1878-0261.13154

Source records

pubmed · retrieved 2026-09-26T15:39:21.846Z